Analysis Hydrogenetics Inc. (HYGN)
5/28/2024
Analysis of Hydrogenetics Inc. (HYGN)
Hydrogenetics Inc. (HYGN) has shown some price volatility in the recent trading days. The stock price closed at $0.00030 on May 23rd, after opening at the same price. The Relative Strength Index (RSI) indicator is at 46.51, indicating a neutral position.Looking at the Moving Average (MA) indicator, the Simple Moving Average (SMA) is at $0.00245, suggesting a potential uptrend. However, the Exponential Moving Average (EMA) and Weighted Moving Average (WMA) are not available for analysis.
On May 15th, the stock price experienced a significant increase, closing at $0.01000 after reaching a high of $0.01000. The RSI indicator was at 59.80, showing a moderate strength in the price movement.
Overall, the stock has shown some price fluctuations, with some days of high volatility and others of stability. It would be important to monitor the moving averages and RSI indicator for potential trends in the future.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year compared to the current one.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a specific company. Here are the key points from the data:1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320. Levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a quarterly basis is $67,150,000,128. Total debt on a quarterly basis is $104,590,000,128. Current ratio is 1.037. Book value per share is $4.837. Total cash per share is $4.379. Total debt to equity ratio is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000. Revenue TTM is $381,623,009,280. Diluted EPS TTM is $6.44. Gross profit TTM is $169,148,000,000. Revenue per share TTM is $24.537. Net income to common TTM is $100,389,003,264. Quarterly revenue growth is -4.3%. Quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets**: Return on assets TTM is 22.073999%.
- **Return on Equity**: Return on equity TTM is 147.25%.
2. **Stock Statistics**:
- Short ratio is 1.66.
- Float shares are 15,308,320,742.
- Shares short are 94,308,265.
- Average 10-day volume is 52,903,608.
- Average 90-day volume is 62,823,269.
- Shares outstanding are 15,334,099,968.
- Percent held by insiders is 5.22%.
- Percent held by institutions is 57.555%.
- Short percent of shares outstanding is 0.62%.
3. **Valuations Metrics**:
- PEG ratio is 26.213001.
- Forward PE ratio is 26.213001.
- Trailing PE ratio is 29.428572.
- Enterprise value is $2,948,462,018,560.
- Price to book ratio on a quarterly basis is 39.181313.
- Price to sales TTM is 7.6151557.
- Enterprise to EBITDA ratio is 22.745.
- Enterprise to revenue ratio is 7.726.
- Market capitalization is $2,906,118,684,672.
4. **Stock Price Summary**:
- Beta is 1.264.
- 50-day moving average is $173.6936.
- 200-day moving average is $180.7906.
- 52-week low is $164.08.
- 52-week high is $199.62.
- 52-week change is 8.253%.
5. **Dividends and Splits**:
- Payout ratio is 14.93%.
- Dividend date is May 16, 2024.
- Last split date is August 31, 2020.
- Ex-dividend date is May 10, 2024.
- Last split factor is a 4-for-1 split.
- Forward annual dividend rate is $1.
- 5-year average dividend yield is 0.73%.
- Forward annual dividend yield is 0.5266761603816345%.
- Trailing annual dividend rate is $0.97.
- Trailing annual dividend yield is 0.5108758755701854%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales have been increasing steadily over the past four fiscal years.
2. The EBITDA has also shown a positive trend, indicating strong operational performance.
3. Net income has been growing consistently, reflecting the company's profitability.
4. Earnings per share (EPS) have shown slight fluctuations but have generally been stable.
5. The company has been able to manage its operating expenses effectively, as seen in the growth of operating income.
6. Despite variations in other income and expenses, the company has maintained a healthy financial position.
7. The basic and diluted shares outstanding have remained relatively constant over the years.
8. Overall, the financial performance of the company, as indicated by its revenues, has been positive and shows a promising outlook.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing over the years, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This data is based on projections from 39 analysts.
Overall, the trend indicates a growth in earnings per share both quarterly and annually, reflecting positive expectations from analysts regarding the company's performance in the upcoming periods.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an annual growth rate of 11%.
- However, when looking at the past 5 years, the company has achieved a higher annual growth rate of approximately 20.1%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly lower growth rate in the short term compared to the long-term projections.
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
